Drug shortage
Ritonavir Oral Powder · AbbVie Inc.
FDA drug shortage · To Be Discontinued · updated Jul 24, 2026
Key facts
| Generic name | Ritonavir Oral Powder |
|---|---|
| Company | AbbVie Inc. |
| Presentation | Norvir, Oral Powder, 100 mg (NDC 0074-3399-30) |
| Dosage form | Oral Powder |
| Status | To Be Discontinued |
| Therapeutic category | Antiviral |
| Package NDCs | 0074-3399-30 |
| First posted | Jul 24, 2026 |
| Last updated | Jul 24, 2026 |
| Discontinued | Jul 24, 2026 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: